Global Organs-on-chips Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
The Global Organs-on-chips Market is expected to grow from USD 12.45 Million in 2018 to USD 87.60 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 32.14%.
'AxoSim, Inc, Emulate, Inc., and HµREL Corporation are placed in forefront due to their excellence in business strategy and product satisfaction'
The positioning of the Global Organs-on-chips Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Organs-on-chips Market including are CN Bio Innovations, Emulate, Inc., InSphero AG, Mimetas, TissUse GmbH, AxoSim, Inc, BioIVT, HemoShear Therapeutics, LLC, HµREL Corporation, Kirkstall Ltd., Nortis, Organovo, Inc., SynVivo, Inc, and Tara Biosystems.
On the basis of Type, the Global Organs-on-chips Market is studied across Artery-on-a-chip, Brain-on-a-chip, Heart-on-a-chip, Kidney-on-a-chip, Lung-on-a-chip, and Skin-on-a-chip.
On the basis of Application, the Global Organs-on-chips Market is studied across Drug Discovery, Physiological Model Development, and Toxicology Research.
On the basis of End User, the Global Organs-on-chips Market is studied across Academic & Research Institutes, Cosmetics Industry, and Pharmaceutical & Biotechnology Companies.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Organs-on-chips Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Organs-on-chips Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Organs-on-chips Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Organs-on-chips Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Organs-on-chips Market
The report answers questions such as:
1. What is the market size of Organs-on-chips market in the Global?
2. What are the factors that affect the growth in the Global Organs-on-chips Market over the forecast period?
3. What is the competitive position in the Global Organs-on-chips Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Organs-on-chips Market?
5. What are the opportunities in the Global Organs-on-chips Market?
6. What are the modes of entering the Global Organs-on-chips Market?
'AxoSim, Inc, Emulate, Inc., and HµREL Corporation are placed in forefront due to their excellence in business strategy and product satisfaction'
The positioning of the Global Organs-on-chips Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Organs-on-chips Market including are CN Bio Innovations, Emulate, Inc., InSphero AG, Mimetas, TissUse GmbH, AxoSim, Inc, BioIVT, HemoShear Therapeutics, LLC, HµREL Corporation, Kirkstall Ltd., Nortis, Organovo, Inc., SynVivo, Inc, and Tara Biosystems.
On the basis of Type, the Global Organs-on-chips Market is studied across Artery-on-a-chip, Brain-on-a-chip, Heart-on-a-chip, Kidney-on-a-chip, Lung-on-a-chip, and Skin-on-a-chip.
On the basis of Application, the Global Organs-on-chips Market is studied across Drug Discovery, Physiological Model Development, and Toxicology Research.
On the basis of End User, the Global Organs-on-chips Market is studied across Academic & Research Institutes, Cosmetics Industry, and Pharmaceutical & Biotechnology Companies.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Organs-on-chips Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Organs-on-chips Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Organs-on-chips Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Organs-on-chips Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Organs-on-chips Market
The report answers questions such as:
1. What is the market size of Organs-on-chips market in the Global?
2. What are the factors that affect the growth in the Global Organs-on-chips Market over the forecast period?
3. What is the competitive position in the Global Organs-on-chips Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Organs-on-chips Market?
5. What are the opportunities in the Global Organs-on-chips Market?
6. What are the modes of entering the Global Organs-on-chips Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Organs-on-chips Market
3.2. Opportunities in the Organs-on-chips Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing focus on developing alternatives for animal testing models
4.2.1.2. Significant increase in research funding and venture capital investments for the development of organs-on-chips
4.2.1.3. Technological advancements and new products launches
4.2.1.4. Growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers
4.2.1.5. Rising need for early detection of drug toxicity to minimize financial losses due to late-stage drug failure
4.2.1.6. Growing initiatives to increase awareness about organs-on-chips technologies
4.2.2. Restraints
4.2.2.1. Issues related to the incorporation of organs-on-chips technologies into existing workflows
4.2.3. Opportunities
4.2.3.1. Growing focus on drug discovery activities
4.2.3.2. Application of organs-on-chips in oncology research
4.2.3.3. Development of multiple-organs-on-a-chip models
4.2.4. Challenges
4.2.4.1. Complexity of organs-on-chips models
4.2.4.2. Dearth of skilled professionals
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
4.4.1. Developments In The Testing Of Human Organs-On-Chips
4.4.2. Organ-On-Chip Technology In Space
4.4.3. Automated Monitoring Of Organs-On-Chips
4.4.4. 3D Printing Of Organs-On Chips
4.4.5. Investment In Integration Of Individual Organs-on-Chips Into Humans-on-Chips
5. GLOBAL ORGANS-ON-CHIPS MARKET, BY TYPE
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Artery-on-a-chip
5.4. Brain-on-a-chip
5.5. Heart-on-a-chip
5.6. Kidney-on-a-chip
5.7. Lung-on-a-chip
5.8. Skin-on-a-chip
6. GLOBAL ORGANS-ON-CHIPS MARKET, BY APPLICATION
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Drug Discovery
6.4. Physiological Model Development
6.5. Toxicology Research
7. GLOBAL ORGANS-ON-CHIPS MARKET, BY END USER
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Academic & Research Institutes
7.4. Cosmetics Industry
7.5. Pharmaceutical & Biotechnology Companies
8. GLOBAL ORGANS-ON-CHIPS MARKET, BY GEOGRAPHY
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom
9. COMPETITIVE LANDSCAPE
9.1. 360iResearch FPNV Positioning Matrix for Global Organs-on-chips Market
9.2. Market Vendor Ranking Analysis for Global Organs-on-chips Market
9.3. Competitive News Feed Analysis for Global Organs-on-chips Market
10. COMPANY USABILITY PROFILES
10.1. CN Bio Innovations
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. Emulate, Inc.
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. InSphero AG
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. Mimetas
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. TissUse GmbH
10.5.1. Overview
10.5.2. Strategy
10.5.3. SWOT
10.6. AxoSim, Inc
10.7. BioIVT
10.8. HemoShear Therapeutics, LLC
10.9. HµREL Corporation
10.10. Kirkstall Ltd.
10.11. Nortis
10.12. Organovo, Inc.
10.13. SynVivo, Inc
10.14. Tara Biosystems
11. APPENDIX
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Organs-on-chips Market
3.2. Opportunities in the Organs-on-chips Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing focus on developing alternatives for animal testing models
4.2.1.2. Significant increase in research funding and venture capital investments for the development of organs-on-chips
4.2.1.3. Technological advancements and new products launches
4.2.1.4. Growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers
4.2.1.5. Rising need for early detection of drug toxicity to minimize financial losses due to late-stage drug failure
4.2.1.6. Growing initiatives to increase awareness about organs-on-chips technologies
4.2.2. Restraints
4.2.2.1. Issues related to the incorporation of organs-on-chips technologies into existing workflows
4.2.3. Opportunities
4.2.3.1. Growing focus on drug discovery activities
4.2.3.2. Application of organs-on-chips in oncology research
4.2.3.3. Development of multiple-organs-on-a-chip models
4.2.4. Challenges
4.2.4.1. Complexity of organs-on-chips models
4.2.4.2. Dearth of skilled professionals
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
4.4.1. Developments In The Testing Of Human Organs-On-Chips
4.4.2. Organ-On-Chip Technology In Space
4.4.3. Automated Monitoring Of Organs-On-Chips
4.4.4. 3D Printing Of Organs-On Chips
4.4.5. Investment In Integration Of Individual Organs-on-Chips Into Humans-on-Chips
5. GLOBAL ORGANS-ON-CHIPS MARKET, BY TYPE
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Artery-on-a-chip
5.4. Brain-on-a-chip
5.5. Heart-on-a-chip
5.6. Kidney-on-a-chip
5.7. Lung-on-a-chip
5.8. Skin-on-a-chip
6. GLOBAL ORGANS-ON-CHIPS MARKET, BY APPLICATION
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Drug Discovery
6.4. Physiological Model Development
6.5. Toxicology Research
7. GLOBAL ORGANS-ON-CHIPS MARKET, BY END USER
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Academic & Research Institutes
7.4. Cosmetics Industry
7.5. Pharmaceutical & Biotechnology Companies
8. GLOBAL ORGANS-ON-CHIPS MARKET, BY GEOGRAPHY
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom
9. COMPETITIVE LANDSCAPE
9.1. 360iResearch FPNV Positioning Matrix for Global Organs-on-chips Market
9.2. Market Vendor Ranking Analysis for Global Organs-on-chips Market
9.3. Competitive News Feed Analysis for Global Organs-on-chips Market
10. COMPANY USABILITY PROFILES
10.1. CN Bio Innovations
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. Emulate, Inc.
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. InSphero AG
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. Mimetas
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. TissUse GmbH
10.5.1. Overview
10.5.2. Strategy
10.5.3. SWOT
10.6. AxoSim, Inc
10.7. BioIVT
10.8. HemoShear Therapeutics, LLC
10.9. HµREL Corporation
10.10. Kirkstall Ltd.
10.11. Nortis
10.12. Organovo, Inc.
10.13. SynVivo, Inc
10.14. Tara Biosystems
11. APPENDIX
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details
